Emster Kurt VON
SEC-identified person · CIK 1252524 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Jasper Therapeutics, Inc. JSPR | Director | filed 2021–2025 |
| Cymabay Therapeutics, Inc. CYMA | Director | filed 2017–2024 |
| Vaxcyte, Inc. PCVX | Director | filed 2020–2021 |
| Vera Therapeutics, Inc. VERA | Director | filed 2021–2021 |
| Crispr Therapeutics AG CRSP | Director | filed 2016–2019 |
| Somaxon Pharmaceuticals, Inc. somx | Director | filed 2006–2013 |
| Facet Biotech Corp FACT | Director | filed 2009–2010 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.